Search filters

List of works by Charles M. Beasley

A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse

scientific article published on December 1, 2003

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia

scientific article published in June 1998

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil

scientific article published in April 2004

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis

scientific article published in November 2000

All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis

scientific article published on 01 June 2007

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

scientific article published on 01 September 1997

Blood pressure changes during short-term fluoxetine treatment.

scientific article published on February 1999

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

scientific article

Design and analysis considerations for thorough QT studies employing conventional (10 s, 12-lead) ECG recordings

scientific article published on 01 November 2008

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders

scientific article published in October 1997

Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis

scientific article published on 25 May 2006

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers.

scientific article published on February 2013

Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.

scientific article

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

scientific article published on December 1998

Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial

scientific article published in September 2005

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder

scientific article published on 20 July 2007

Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials

scientific article

Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment

scientific article (publication date: April 2002)

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study

scientific article published on July 1, 1997

Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy.

scientific article published in December 2001

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

scientific article

Fluoxetine efficacy in menopausal women with and without estrogen replacement

scientific article published on 01 September 1999

Fluoxetine in Depressed Patients on Dialysis

scientific article published on January 1, 1997

Fluoxetine in medically stable, depressed geriatric patients: effects on weight

scientific article published in October 1997

Fluoxetine: a review of receptor and functional effects and their clinical implications.

scientific article

Fluoxetine: no association with suicidality in obsessive-compulsive disorder

scientific article published on 01 January 1992

Hematologic reference ranges in a population of patients with schizophrenia

scientific article

Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.

scientific article published in June 2002

Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment?

scientific article published in February 2006

Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients

scientific article published on 01 December 1997

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial

scientific article

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial

scientific article published in August 1999

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

scientific article

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

scientific article published on 01 February 1996

Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial

scientific article published in January 1998

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

scientific article published on 01 March 1996

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

scientific article

Optimal Length of Continuation Therapy in Depression: A Prospective Assessment During Long-Term Fluoxetine Treatment

scientific article published on September 1, 1998

Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia

scientific article published on 01 December 1997

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report

scientific article published on 13 July 2010

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement

scientific article published on August 2010

Systematic decrements in QTc between the first and second day of contiguous daily ECG recordings under controlled conditions

scientific article published on 28 April 2011

Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.

scientific article published in September 2003

Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial

scientific article published in May 2005

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

scientific article published on July 25, 1997

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval

scientific article published in August 2005

Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.

scientific article published on January 2007

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo

scientific article published on 01 April 1998

Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials

scientific article published on 17 June 2010